Creating and testing new remedies or vaccines for people nearly at all times requires animal trials, however these experiments can generally take years to finish and might elevate moral issues concerning the animals’ remedy. Now, researchers reporting in ACS Central Science have developed a brand new testing platform that encapsulates B cells — among the most necessary parts of the immune system — into miniature ‘organoids’ to make vaccine screening faster and significantly cut back the variety of animals wanted.